Oestrogenotherapie apres la menopause et protection cardio-vasculaire: discordance entre les observations epidemiologiques et les resultats d'essais therapeutiques.

Scheen, André

No full text

Article (Scientific journals)

Oestrogenotherapie apres la menopause et protection cardio-vasculaire: discordance entre les observations epidemiologiques et les resultats d'essais therapeutiques.

Scheen, André

2000 • In Revue Médicale de Liège, 55 (9), p. 886-8

Peer reviewed

Permalink
https://hdl.handle.net/2268/12249

PubMed
11105606

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Adult; Aged; Cardiovascular Agents/therapeutic use; Cholesterol, HDL/blood; Cholesterol, LDL/blood; Clinical Trials as Topic; Coronary Disease/prevention & control; Dietary Fats/administration & dosage; Epidemiologic Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP)/therapeutic use; Fatty Acids/administration & dosage; Female; Humans; Middle Aged; Placebos; Postmenopause; Protective Agents/therapeutic use; Smoking

Abstract :

[en] Based upon the positive results of a large epidemiological study and the negative results of an interventional clinical trial recently published in the New England Journal of Medicine, we will briefly discuss the impact of estrogen replacement therapy on the protection against coronary heart disease in postmenopausal women.

Disciplines :

Pharmacy, pharmacology & toxicology
Public health, health care sciences & services

Author, co-author :

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Oestrogenotherapie apres la menopause et protection cardio-vasculaire: discordance entre les observations epidemiologiques et les resultats d'essais therapeutiques.

Alternative titles :

[en] Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials

Publication date :

2000

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

Issue :

Pages :

886-8

Peer reviewed :

Peer reviewed

Available on ORBi :

since 06 May 2009

Statistics

Number of views

52 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Gaspard, U., Van den Brule, F., La substitution hormonale postmenopausique: Recommandations pratiques (1999) Rev Med Liege, 54, pp. 481-488
Foidart, J.M., Desreux, J., Pintiaux, A., Les traitements post-menopause a revoir? Une polemique nouvelle! (2000) Rev Med Liege, 55, pp. 156-160
Seed, M., Hormone replacement therapy and cardiovascular disease (1999) Curr Opin Lipidol, 10, pp. 581-587
Nabel, E.G., Coronary heart disease in women - An ounce of prevention (2000) N Engl J Med, 343, pp. 572-574
Mendelsohn, M.E., Karas, R.H., The protective effects of estrogen on the cardiovascular system (1999) N Engl J Med, 340, pp. 1801-1811
Reginster, J.Y., Betz, R., Evidence-Based Medicine (2000) Rev Med Liege, 55, pp. 211-215. , Apport des etudes epidemiologiques
Scheen, A.J., Evidence-Based Medicine (2000) Rev Med Liege, 55, pp. 216-219. , Apport des essais cliniques controles
Hu, F.B., Stampfer, M.J., Manson, J.E., Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women (2000) N Engl J Med, 343, pp. 530-537
Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Effects of estrogen replacement on the progression of coronary-artery atherosclerosis (2000) N Engl J Med, 343, pp. 522-529
Archbold, R.A., Timmis, A.D., Modification of coronary artery disease progression by cholesterol-lowering therapy: The angiographic studies (1999) Curr Opin Lipidol, 10, pp. 527-534
Hulley, S., Grady, D., Bush, T., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (1998) JAMA, 280, pp. 605-613
Barrett-Connor, E., Wenger, N.K., Grady, D., Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene (1998) J Women Health, 7, pp. 839-847